pmc logo imageJournal ListSearchpmc logo image
Logo of biochemjJournal URL: redirect3.cgi?&&auth=0zKBMnh4a7rqTNkh5TDSp8cNEJhSBSDRsWibqMQCe&reftype=publisher&artid=1222864&article-id=1222864&iid=122156&issue-id=122156&jid=74&journal-id=74&FROM=Article|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.biochemj.org/bj/currentissue.htm
Biochem J. 2002 October 1; 367(Pt 1): 113–120.
doi: 10.1042/BJ20020675.
PMCID: PMC1222864
Determinants of adenophostin A binding to inositol trisphosphate receptors.
Stephen A Morris, Edmund P Nerou, Andrew M Riley, Barry V L Potter, and Colin W Taylor
Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, U.K.
Abstract
Inositol 1,4,5-trisphosphate (IP(3)) receptors from cerebellum and recombinant type 1 IP(3) receptors expressed in Sf9 cells had indistinguishable affinities for IP(3) ( K (d)=6.40+/-0.48 nM) and adenophostin A ( K (d)=0.89+/-0.05 nM). In cytosol-like medium, each of the three mammalian IP(3) receptor subtypes when expressed in Sf9 cells bound adenophostin A with greater affinity than IP(3). It has been suggested that adenophostin A binds with high affinity only in the presence of ATP, but we found that adenophostin A similarly displaced [(3)H]IP(3) from type 1 IP(3) receptors whatever the ATP concentration. N-terminal fragments of the type 1 receptor were expressed with and without the S1 splice site; its removal had no effect on [(3)H]IP(3) binding to the 1-604 protein, but abolished binding to the 224-604 protein. The 1-604 fragment and full-length receptor bound adenophostin A with the same affinity, but the fragment had 3-fold greater affinity for IP(3), suggesting that C-terminal residues selectively inhibit IP(3) binding. The 224-604S1(+) fragment bound IP(3) and adenophostin A with increased affinity, but as with the 1-604 fragment it bound adenophostin A with only 2-fold greater affinity than IP(3). High-affinity binding of adenophostin A may be partially determined by its 2'-phosphate interacting more effectively than the 1-phosphate of IP(3) with residues within the IP(3)-binding core. This may account for the 2-fold greater affinity of adenophostin A relative to IP(3) for the minimal IP(3)-binding domain. In addition we suggest that C-terminal residues, which impede access of IP(3), may selectively interact with adenophostin A to allow it unhindered access to the IP(3)-binding domain.
Full Text
The Full Text of this article is available as a PDF (208K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Taylor, CW; Genazzani, AA; Morris, SA. Expression of inositol trisphosphate receptors. Cell Calcium. 1999 Dec;26(6):237–251. [PubMed]
  • Nerou, EP; Riley, AM; Potter, BV; Taylor, CW. Selective recognition of inositol phosphates by subtypes of the inositol trisphosphate receptor. Biochem J. 2001 Apr 1;355(Pt 1):59–69. [PubMed]
  • Patel, S; Joseph, SK; Thomas, AP. Molecular properties of inositol 1,4,5-trisphosphate receptors. Cell Calcium. 1999 Mar;25(3):247–264. [PubMed]
  • Takahashi, S; Kinoshita, T; Takahashi, M. Adenophostins A and B: potent agonists of inositol-1,4,5-trisphosphate receptor produced by Penicillium brevicompactum. Structure elucidation. J Antibiot (Tokyo). 1994 Jan;47(1):95–100. [PubMed]
  • Correa, V; Riley, AM; Shuto, S; Horne, G; Nerou, EP; Marwood, RD; Potter, BV; Taylor, CW. Structural determinants of adenophostin A activity at inositol trisphosphate receptors. Mol Pharmacol. 2001 May;59(5):1206–1215. [PubMed]
  • Hirota, J; Michikawa, T; Miyawaki, A; Takahashi, M; Tanzawa, K; Okura, I; Furuichi, T; Mikoshiba, K. Adenophostin-medicated quantal Ca2+ release in the purified and reconstituted inositol 1,4,5-trisphosphate receptor type 1. FEBS Lett. 1995 Jul 17;368(2):248–252. [PubMed]
  • Missiaen, L; Parys, JB; Sienaert, I; Maes, K; Kunzelmann, K; Takahashi, M; Tanzawa, K; De Smedt, H. Functional properties of the type-3 InsP3 receptor in 16HBE14o- bronchial mucosal cells. J Biol Chem. 1998 Apr 10;273(15):8983–8986. [PubMed]
  • Takahashi, M; Tanzawa, K; Takahashi, S. Adenophostins, newly discovered metabolites of Penicillium brevicompactum, act as potent agonists of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1994 Jan 7;269(1):369–372. [PubMed]
  • Broad, LM; Armstrong, DL; Putney, JW., Jr Role of the inositol 1,4,5-trisphosphate receptor in Ca(2+) feedback inhibition of calcium release-activated calcium current (I(crac)). J Biol Chem. 1999 Nov 12;274(46):32881–32888. [PubMed]
  • Mak, DO; McBride, S; Foskett, JK. ATP-dependent adenophostin activation of inositol 1,4,5-trisphosphate receptor channel gating: kinetic implications for the durations of calcium puffs in cells. J Gen Physiol. 2001 Apr;117(4):299–314. [PubMed]
  • Parekh, Anant B; Riley, Andrew M; Potter, Barry V L. Adenophostin A and ribophostin, but not inositol 1,4,5-trisphosphate or manno-adenophostin, activate the Ca2+ release-activated Ca2+ current, I(CRAC), in weak intracellular Ca2+ buffer. Biochem J. 2002 Jan 1;361(Pt 1):133–141. [PubMed]
  • Hotoda, H; Murayama, K; Miyamoto, S; Iwata, Y; Takahashi, M; Kawase, Y; Tanzawa, K; Kaneko, M. Molecular recognition of adenophostin, a very potent Ca2+ inducer, at the D-myo-inositol 1,4,5-trisphosphate receptor. Biochemistry. 1999 Jul 20;38(29):9234–9241. [PubMed]
  • Felemez, M; Marwood, RD; Potter, BV; Spiess, B. Inframolecular studies of the protonation of adenophostin A: comparison with 1-D-myo-inositol 1,4,5-trisphosphate. Biochem Biophys Res Commun. 1999 Dec 20;266(2):334–340. [PubMed]
  • Yoshikawa, F; Morita, M; Monkawa, T; Michikawa, T; Furuichi, T; Mikoshiba, K. Mutational analysis of the ligand binding site of the inositol 1,4,5-trisphosphate receptor. J Biol Chem. 1996 Jul 26;271(30):18277–18284. [PubMed]
  • Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K. Cooperative formation of the ligand-binding site of the inositol 1,4, 5-trisphosphate receptor by two separable domains. J Biol Chem. 1999 Jan 1;274(1):328–334. [PubMed]
  • Joseph, SK; Pierson, S; Samanta, S. Trypsin digestion of the inositol trisphosphate receptor: implications for the conformation and domain organization of the protein. Biochem J. 1995 May 1;307(Pt 3):859–865. [PubMed]
  • Mignery, GA; Südhof, TC. The ligand binding site and transduction mechanism in the inositol-1,4,5-triphosphate receptor. EMBO J. 1990 Dec;9(12):3893–3898. [PubMed]
  • Nakade, S; Maeda, N; Mikoshiba, K. Involvement of the C-terminus of the inositol 1,4,5-trisphosphate receptor in Ca2+ release analysed using region-specific monoclonal antibodies. Biochem J. 1991 Jul 1;277(Pt 1):125–131. [PubMed]
  • Vanlingen, S; Sipma, H; De Smet, P; Callewaert, G; Missiaen, L; De Smedt, H; Parys, JB. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms. Biochem J. 2000 Mar 1;346(Pt 2):275–280. [PubMed]
  • Richardson, A; Taylor, CW. Effects of Ca2+ chelators on purified inositol 1,4,5-trisphosphate (InsP3) receptors and InsP3-stimulated Ca2+ mobilization. J Biol Chem. 1993 Jun 5;268(16):11528–11533. [PubMed]
  • Patel, S; Morris, SA; Adkins, CE; O'Beirne, G; Taylor, CW. Ca2+-independent inhibition of inositol trisphosphate receptors by calmodulin: redistribution of calmodulin as a possible means of regulating Ca2+ mobilization. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11627–11632. [PubMed]
  • Mignery, GA; Südhof, TC; Takei, K; De Camilli, P. Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature. 1989 Nov 9;342(6246):192–195. [PubMed]
  • Bradford, MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. [PubMed]
  • Newton, CL; Mignery, GA; Südhof, TC. Co-expression in vertebrate tissues and cell lines of multiple inositol 1,4,5-trisphosphate (InsP3) receptors with distinct affinities for InsP3. J Biol Chem. 1994 Nov 18;269(46):28613–28619. [PubMed]
  • Wojcikiewicz, RJ; Luo, SG. Differences among type I, II, and III inositol-1,4,5-trisphosphate receptors in ligand-binding affinity influence the sensitivity of calcium stores to inositol-1,4,5-trisphosphate. Mol Pharmacol. 1998 Apr;53(4):656–662. [PubMed]
  • Bezprozvanny, I; Ehrlich, BE. ATP modulates the function of inositol 1,4,5-trisphosphate-gated channels at two sites. Neuron. 1993 Jun;10(6):1175–1184. [PubMed]
  • Maes, K; Missiaen, L; Parys, JB; Sienaert, I; Bultynck, G; Zizi, M; De Smet, P; Casteels, R; De Smedt, H. Adenine-nucleotide binding sites on the inositol 1,4,5-trisphosphate receptor bind caffeine, but not adenophostin A or cyclic ADP-ribose. Cell Calcium. 1999 Feb;25(2):143–152. [PubMed]
  • Beecroft, MD; Marchant, JS; Riley, AM; Van Straten, NC; Van der Marel, GA; Van Boom, JH; Potter, BV; Taylor, CW. Acyclophostin: a ribose-modified analog of adenophostin A with high affinity for inositol 1,4,5-trisphosphate receptors and pH-dependent efficacy. Mol Pharmacol. 1999 Jan;55(1):109–117. [PubMed]
  • Marchant, JS; Beecroft, MD; Riley, AM; Jenkins, DJ; Marwood, RD; Taylor, CW; Potter, BV. Disaccharide polyphosphates based upon adenophostin A activate hepatic D-myo-inositol 1,4,5-trisphosphate receptors. Biochemistry. 1997 Oct 21;36(42):12780–12790. [PubMed]
  • Nunn, DL; Taylor, CW. Liver inositol, 1,4,5-trisphosphate-binding sites are the Ca2(+)-mobilizing receptors. Biochem J. 1990 Aug 15;270(1):227–232. [PubMed]
  • Yoshikawa, F; Uchiyama, T; Iwasaki, H; Tomomori-Satoh, C; Tanaka, T; Furuichi, T; Mikoshiba, K. High efficient expression of the functional ligand binding site of the inositol 1,4,5-triphosphate receptor in Escherichia coli. Biochem Biophys Res Commun. 1999 Apr 21;257(3):792–797. [PubMed]
  • Glouchankova, L; Krishna, UM; Potter, BV; Falck, JR; Bezprozvanny, I. Association of the inositol (1,4,5)-trisphosphate receptor ligand binding site with phosphatidylinositol (4,5)-bisphosphate and adenophostin A. Mol Cell Biol Res Commun. 2000 Mar;3(3):153–158. [PubMed]
  • Ramos-Franco, J; Caenepeel, S; Fill, M; Mignery, G. Single channel function of recombinant type-1 inositol 1,4,5-trisphosphate receptor ligand binding domain splice variants. Biophys J. 1998 Dec;75(6):2783–2793. [PubMed]
  • Yoshikawa, F; Iwasaki, H; Michikawa, T; Furuichi, T; Mikoshiba, K. Trypsinized cerebellar inositol 1,4,5-trisphosphate receptor. Structural and functional coupling of cleaved ligand binding and channel domains. J Biol Chem. 1999 Jan 1;274(1):316–327. [PubMed]
  • Adkins, CE; Wissing, F; Potter, BV; Taylor, CW. Rapid activation and partial inactivation of inositol trisphosphate receptors by adenophostin A. Biochem J. 2000 Dec 15;352(Pt 3):929–933. [PubMed]